Joshua A. Beckman

Cardiology and Cardiovascular Medicine · 2002–2022

A researcher in the Science corpus: 20 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Cardiology and Cardiovascular Medicine — 426 citations into it
• Surgery — 246 citations into it
• Endocrinology, Diabetes and Metabolism — 160 citations into it
• Pulmonary and Respiratory Medicine — 157 citations into it
• Radiology, Nuclear Medicine and Imaging — 78 citations into it
• Cancer Research — 19 citations into it
• Economics and Econometrics — 15 citations into it

Whom Joshua A. Beckman trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. G. Moneta
2. Rury R. Holman
3. S. Nissen
4. B. J. Gersh
5. AndrewJ. S. Coats
6. P. P. Toth
7. Peter Libby
8. David J. Brenner
9. R. Collins

Who trusts Joshua A. Beckman overall

1. Brandon H Hidaka
2. M. Creager
3. G. Moneta

Papers from Joshua A. Beckman's perspective

Ordered by how strongly the researchers Joshua A. Beckman trusts endorse each paper. Same corpus, a different order for every researcher.

1. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. (Diabetes Care)
2. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.
3. EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION
4. Glucose control and vascular complications in veterans with type 2 diabetes. (New England Journal of Medicine)
5. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association… (Journal of the American College of Cardiology)
6. 10-year follow-up of intensive glucose control in type 2 diabetes. (New England Journal of Medicine)
7. Long-term follow-up after tight control of blood pressure in type 2 diabetes. (New England Journal of Medicine)
8. Effects of Intensive Glucose Lowering in Type 2 Diabetes
9. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage (Nature)
10. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes… (Diabetes Care)

Their papers

• 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease (2022) — 920 citations
• 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines (2022) — 758 citations
• COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020) — 2,222 citations
• Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic (2020) — 1,681 citations
• 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary (2019) — 1,563 citations
• 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. (2019) — 1,222 citations
• 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2019) — 4,134 citations
• 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) — 1,986 citations
• 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014) — 743 citations
• Management of Patients With Peripheral Artery Disease (Compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations) (2013) — 664 citations
• Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I (2013) — 1,888 citations
• Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. (2013) — 612 citations
• 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2011) — 952 citations
• 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame (2010) — 1,478 citations
• 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, Ame (2010) — 646 citations
• Partial thrombosis of the false lumen in patients with acute type B aortic dissection. (2007) — 672 citations
• ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiov (2007) — 898 citations
• Advanced glycation end products: sparking the development of diabetic vascular injury. (2006) — 2,278 citations
• Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I (2003) — 1,136 citations
• Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. (2002) — 3,010 citations